NASD · Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Aurora Cannabis Inc is a micro cap company (market value under $300 million) in the Drug Manufacturers - Specialty & Generic industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Aurora Cannabis Inc stock.
Overvalued: intrinsic value $3.37 per share, market price $4.06, margin of safety -20.6% (as of 2026-10-30).
Its liquidation floor, current assets minus every liability, values the shares at $3.37; the price of $4.06 is 21% above that value.
All 84 Drug Manufacturers - Specialty & Generic stocks
13 more in this industry show a wider margin of safety.
ACB is overvalued (as of the 2026-10-30 close). Its liquidation floor, current assets minus every liability, values the shares at $3.37; the price of $4.06 is 21% above that value.
$3.37 per share (as of the 2026-10-30 close), against a market price of $4.06. That is a margin of safety of -20.6%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.